SARS2 and coinfection: Clinical studies have demonstrated that co‐infection with influenza viruses and SARS2 can exacerbate disease severity and increase mortality rates.[66, 67] Studies in mice have shown that co‐infection with IAV and SARS2 results in enhanced IAV replication and more pronounced inflammatory responses in the lungs.[68] However, the mechanisms underlying this remain poorly understood.